Back
Verrica Pharmaceuticals 10K Form
Sell
17
VRCA
Verrica Pharmaceuticals
Last Price:
$0.47
Seasonality Move:
-11.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-05 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
| 2020-05-07 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
| 2020-03-13 | 10K | VRCA/Verrica Pharmaceuticals Annual |
| 2019-11-06 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
| 2019-08-07 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
| 2019-05-07 | 10Q | VRCA/Verrica Pharmaceuticals Quarterly |
Receive VRCA News And Ratings
See the #1 stock for the next 7 days that we like better than VRCA
VRCA Financial Statistics
Sales & Book Value
| Annual Sales: | $7.6M |
|---|---|
| Cash Flow: | $-16.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.11 |
| Price / Book: | 192.69 |
Profitability
| EPS (TTM): | -1.54000 |
|---|---|
| Net Income (TTM): | $-76.6M |
| Gross Margin: | $4.8M |
| Return on Equity: | -2619.46% |
| Return on Assets: | -133.43% |
Verrica Pharmaceuticals Earnings Forecast
Key Verrica Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 4 years for VRCA is 63.79%.
-
The Selling, General & Administrative Expenses for VRCA have been equal to 777.45% of Gross Profit Margin.
-
The Research & Development expenses have been 156.49% of Revenue.
-
The Net Earning history of VRCA is -1,012.15% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Verrica Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VRCA |
| CUSIP: | 92511W |
| Website: | verrica.com |
Debt
| Debt-to-Equity Ratio: | -4.45 |
|---|---|
| Current Ratio: | 1.76 |
| Quick Ratio: | 1.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VRCA Technical Analysis vs Fundamental Analysis
Sell
17
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a SellThe current Verrica Pharmaceuticals [VRCA] share price is $0.49. The Score for VRCA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.